Global T-cell engaging bsAbs Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global T-cell engaging bsAbs Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for T-cell engaging bsAbs Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for T-cell engaging bsAbs Drugs by Country/Region, 2017, 2022 & 2028

2.2 T-cell engaging bsAbs Drugs Segment by Type

2.2.1 Blincyto

2.2.2 Kimmtrak

2.3 T-cell engaging bsAbs Drugs Sales by Type

2.3.1 Global T-cell engaging bsAbs Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global T-cell engaging bsAbs Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global T-cell engaging bsAbs Drugs Sale Price by Type (2017-2022)

2.4 T-cell engaging bsAbs Drugs Segment by Application

2.4.1 Hematological Cancers

2.4.2 Solid Tumors

2.5 T-cell engaging bsAbs Drugs Sales by Application

2.5.1 Global T-cell engaging bsAbs Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global T-cell engaging bsAbs Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global T-cell engaging bsAbs Drugs Sale Price by Application (2017-2022)

3 Global T-cell engaging bsAbs Drugs by Company

3.1 Global T-cell engaging bsAbs Drugs Breakdown Data by Company

3.1.1 Global T-cell engaging bsAbs Drugs Annual Sales by Company (2020-2022)

3.1.2 Global T-cell engaging bsAbs Drugs Sales Market Share by Company (2020-2022)

3.2 Global T-cell engaging bsAbs Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global T-cell engaging bsAbs Drugs Revenue by Company (2020-2022)

3.2.2 Global T-cell engaging bsAbs Drugs Revenue Market Share by Company (2020-2022)

3.3 Global T-cell engaging bsAbs Drugs Sale Price by Company

3.4 Key Manufacturers T-cell engaging bsAbs Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers T-cell engaging bsAbs Drugs Product Location Distribution

3.4.2 Players T-cell engaging bsAbs Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for T-cell engaging bsAbs Drugs by Geographic Region

4.1 World Historic T-cell engaging bsAbs Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global T-cell engaging bsAbs Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global T-cell engaging bsAbs Drugs Annual Revenue by Geographic Region

4.2 World Historic T-cell engaging bsAbs Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global T-cell engaging bsAbs Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global T-cell engaging bsAbs Drugs Annual Revenue by Country/Region

4.3 Americas T-cell engaging bsAbs Drugs Sales Growth

4.4 APAC T-cell engaging bsAbs Drugs Sales Growth

4.5 Europe T-cell engaging bsAbs Drugs Sales Growth

4.6 Middle East & Africa T-cell engaging bsAbs Drugs Sales Growth

5 Americas

5.1 Americas T-cell engaging bsAbs Drugs Sales by Country

5.1.1 Americas T-cell engaging bsAbs Drugs Sales by Country (2017-2022)

5.1.2 Americas T-cell engaging bsAbs Drugs Revenue by Country (2017-2022)

5.2 Americas T-cell engaging bsAbs Drugs Sales by Type

5.3 Americas T-cell engaging bsAbs Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC T-cell engaging bsAbs Drugs Sales by Region

6.1.1 APAC T-cell engaging bsAbs Drugs Sales by Region (2017-2022)

6.1.2 APAC T-cell engaging bsAbs Drugs Revenue by Region (2017-2022)

6.2 APAC T-cell engaging bsAbs Drugs Sales by Type

6.3 APAC T-cell engaging bsAbs Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe T-cell engaging bsAbs Drugs by Country

7.1.1 Europe T-cell engaging bsAbs Drugs Sales by Country (2017-2022)

7.1.2 Europe T-cell engaging bsAbs Drugs Revenue by Country (2017-2022)

7.2 Europe T-cell engaging bsAbs Drugs Sales by Type

7.3 Europe T-cell engaging bsAbs Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa T-cell engaging bsAbs Drugs by Country

8.1.1 Middle East & Africa T-cell engaging bsAbs Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa T-cell engaging bsAbs Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa T-cell engaging bsAbs Drugs Sales by Type

8.3 Middle East & Africa T-cell engaging bsAbs Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of T-cell engaging bsAbs Drugs

10.3 Manufacturing Process Analysis of T-cell engaging bsAbs Drugs

10.4 Industry Chain Structure of T-cell engaging bsAbs Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 T-cell engaging bsAbs Drugs Distributors

11.3 T-cell engaging bsAbs Drugs Customer

12 World Forecast Review for T-cell engaging bsAbs Drugs by Geographic Region

12.1 Global T-cell engaging bsAbs Drugs Market Size Forecast by Region

12.1.1 Global T-cell engaging bsAbs Drugs Forecast by Region (2023-2028)

12.1.2 Global T-cell engaging bsAbs Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global T-cell engaging bsAbs Drugs Forecast by Type

12.7 Global T-cell engaging bsAbs Drugs Forecast by Application

13 Key Players Analysis

13.1 Amgen

13.1.1 Amgen Company Information

13.1.2 Amgen T-cell engaging bsAbs Drugs Product Offered

13.1.3 Amgen T-cell engaging bsAbs Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen Main Business Overview

13.1.5 Amgen Latest Developments

14 Research Findings and Conclusion

Table 1. T-cell engaging bsAbs Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. T-cell engaging bsAbs Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Blincyto

Table 4. Major Players of Kimmtrak

Table 5. Global T-cell engaging bsAbs Drugs Sales by Type (2017-2022) & (Units)

Table 6. Global T-cell engaging bsAbs Drugs Sales Market Share by Type (2017-2022)

Table 7. Global T-cell engaging bsAbs Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global T-cell engaging bsAbs Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global T-cell engaging bsAbs Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global T-cell engaging bsAbs Drugs Sales by Application (2017-2022) & (Units)

Table 11. Global T-cell engaging bsAbs Drugs Sales Market Share by Application (2017-2022)

Table 12. Global T-cell engaging bsAbs Drugs Revenue by Application (2017-2022)

Table 13. Global T-cell engaging bsAbs Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global T-cell engaging bsAbs Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global T-cell engaging bsAbs Drugs Sales by Company (2020-2022) & (Units)

Table 16. Global T-cell engaging bsAbs Drugs Sales Market Share by Company (2020-2022)

Table 17. Global T-cell engaging bsAbs Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global T-cell engaging bsAbs Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global T-cell engaging bsAbs Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers T-cell engaging bsAbs Drugs Producing Area Distribution and Sales Area

Table 21. Players T-cell engaging bsAbs Drugs Products Offered

Table 22. T-cell engaging bsAbs Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global T-cell engaging bsAbs Drugs Sales by Geographic Region (2017-2022) & (Units)

Table 26. Global T-cell engaging bsAbs Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global T-cell engaging bsAbs Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global T-cell engaging bsAbs Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global T-cell engaging bsAbs Drugs Sales by Country/Region (2017-2022) & (Units)

Table 30. Global T-cell engaging bsAbs Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global T-cell engaging bsAbs Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global T-cell engaging bsAbs Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas T-cell engaging bsAbs Drugs Sales by Country (2017-2022) & (Units)

Table 34. Americas T-cell engaging bsAbs Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas T-cell engaging bsAbs Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas T-cell engaging bsAbs Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas T-cell engaging bsAbs Drugs Sales by Type (2017-2022) & (Units)

Table 38. Americas T-cell engaging bsAbs Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas T-cell engaging bsAbs Drugs Sales by Application (2017-2022) & (Units)

Table 40. Americas T-cell engaging bsAbs Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC T-cell engaging bsAbs Drugs Sales by Region (2017-2022) & (Units)

Table 42. APAC T-cell engaging bsAbs Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC T-cell engaging bsAbs Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC T-cell engaging bsAbs Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC T-cell engaging bsAbs Drugs Sales by Type (2017-2022) & (Units)

Table 46. APAC T-cell engaging bsAbs Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC T-cell engaging bsAbs Drugs Sales by Application (2017-2022) & (Units)

Table 48. APAC T-cell engaging bsAbs Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe T-cell engaging bsAbs Drugs Sales by Country (2017-2022) & (Units)

Table 50. Europe T-cell engaging bsAbs Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe T-cell engaging bsAbs Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe T-cell engaging bsAbs Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe T-cell engaging bsAbs Drugs Sales by Type (2017-2022) & (Units)

Table 54. Europe T-cell engaging bsAbs Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe T-cell engaging bsAbs Drugs Sales by Application (2017-2022) & (Units)

Table 56. Europe T-cell engaging bsAbs Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa T-cell engaging bsAbs Drugs Sales by Country (2017-2022) & (Units)

Table 58. Middle East & Africa T-cell engaging bsAbs Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa T-cell engaging bsAbs Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa T-cell engaging bsAbs Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa T-cell engaging bsAbs Drugs Sales by Type (2017-2022) & (Units)

Table 62. Middle East & Africa T-cell engaging bsAbs Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa T-cell engaging bsAbs Drugs Sales by Application (2017-2022) & (Units)

Table 64. Middle East & Africa T-cell engaging bsAbs Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of T-cell engaging bsAbs Drugs

Table 66. Key Market Challenges & Risks of T-cell engaging bsAbs Drugs

Table 67. Key Industry Trends of T-cell engaging bsAbs Drugs

Table 68. T-cell engaging bsAbs Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. T-cell engaging bsAbs Drugs Distributors List

Table 71. T-cell engaging bsAbs Drugs Customer List

Table 72. Global T-cell engaging bsAbs Drugs Sales Forecast by Region (2023-2028) & (Units)

Table 73. Global T-cell engaging bsAbs Drugs Sales Market Forecast by Region

Table 74. Global T-cell engaging bsAbs Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global T-cell engaging bsAbs Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas T-cell engaging bsAbs Drugs Sales Forecast by Country (2023-2028) & (Units)

Table 77. Americas T-cell engaging bsAbs Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC T-cell engaging bsAbs Drugs Sales Forecast by Region (2023-2028) & (Units)

Table 79. APAC T-cell engaging bsAbs Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe T-cell engaging bsAbs Drugs Sales Forecast by Country (2023-2028) & (Units)

Table 81. Europe T-cell engaging bsAbs Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa T-cell engaging bsAbs Drugs Sales Forecast by Country (2023-2028) & (Units)

Table 83. Middle East & Africa T-cell engaging bsAbs Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global T-cell engaging bsAbs Drugs Sales Forecast by Type (2023-2028) & (Units)

Table 85. Global T-cell engaging bsAbs Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global T-cell engaging bsAbs Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global T-cell engaging bsAbs Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global T-cell engaging bsAbs Drugs Sales Forecast by Application (2023-2028) & (Units)

Table 89. Global T-cell engaging bsAbs Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global T-cell engaging bsAbs Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global T-cell engaging bsAbs Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Amgen Basic Information, T-cell engaging bsAbs Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Amgen T-cell engaging bsAbs Drugs Product Offered

Table 94. Amgen T-cell engaging bsAbs Drugs Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Amgen Main Business

Table 96. Amgen Latest Developments

Table 97. Immunocore Basic Information, T-cell engaging bsAbs Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Immunocore T-cell engaging bsAbs Drugs Product Offered

Table 99. Immunocore T-cell engaging bsAbs Drugs Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Immunocore Main Business

Table 101. Immunocore Latest Developments

List of Figures

Figure 1. Picture of T-cell engaging bsAbs Drugs

Figure 2. T-cell engaging bsAbs Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global T-cell engaging bsAbs Drugs Sales Growth Rate 2017-2028 (Units)

Figure 7. Global T-cell engaging bsAbs Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. T-cell engaging bsAbs Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Blincyto

Figure 10. Product Picture of Kimmtrak

Figure 11. Global T-cell engaging bsAbs Drugs Sales Market Share by Type in 2021

Figure 12. Global T-cell engaging bsAbs Drugs Revenue Market Share by Type (2017-2022)

Figure 13. T-cell engaging bsAbs Drugs Consumed in Hematological Cancers

Figure 14. Global T-cell engaging bsAbs Drugs Market: Hematological Cancers (2017-2022) & (Units)

Figure 15. T-cell engaging bsAbs Drugs Consumed in Solid Tumors

Figure 16. Global T-cell engaging bsAbs Drugs Market: Solid Tumors (2017-2022) & (Units)

Figure 17. Global T-cell engaging bsAbs Drugs Sales Market Share by Application (2017-2022)

Figure 18. Global T-cell engaging bsAbs Drugs Revenue Market Share by Application in 2021

Figure 19. T-cell engaging bsAbs Drugs Revenue Market by Company in 2021 ($ Million)

Figure 20. Global T-cell engaging bsAbs Drugs Revenue Market Share by Company in 2021

Figure 21. Global T-cell engaging bsAbs Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global T-cell engaging bsAbs Drugs Revenue Market Share by Geographic Region in 2021

Figure 23. Global T-cell engaging bsAbs Drugs Sales Market Share by Region (2017-2022)

Figure 24. Global T-cell engaging bsAbs Drugs Revenue Market Share by Country/Region in 2021

Figure 25. Americas T-cell engaging bsAbs Drugs Sales 2017-2022 (Units)

Figure 26. Americas T-cell engaging bsAbs Drugs Revenue 2017-2022 ($ Millions)

Figure 27. APAC T-cell engaging bsAbs Drugs Sales 2017-2022 (Units)

Figure 28. APAC T-cell engaging bsAbs Drugs Revenue 2017-2022 ($ Millions)

Figure 29. Europe T-cell engaging bsAbs Drugs Sales 2017-2022 (Units)

Figure 30. Europe T-cell engaging bsAbs Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa T-cell engaging bsAbs Drugs Sales 2017-2022 (Units)

Figure 32. Middle East & Africa T-cell engaging bsAbs Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Americas T-cell engaging bsAbs Drugs Sales Market Share by Country in 2021

Figure 34. Americas T-cell engaging bsAbs Drugs Revenue Market Share by Country in 2021

Figure 35. United States T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC T-cell engaging bsAbs Drugs Sales Market Share by Region in 2021

Figure 40. APAC T-cell engaging bsAbs Drugs Revenue Market Share by Regions in 2021

Figure 41. China T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. India T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe T-cell engaging bsAbs Drugs Sales Market Share by Country in 2021

Figure 48. Europe T-cell engaging bsAbs Drugs Revenue Market Share by Country in 2021

Figure 49. Germany T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. France T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa T-cell engaging bsAbs Drugs Sales Market Share by Country in 2021

Figure 55. Middle East & Africa T-cell engaging bsAbs Drugs Revenue Market Share by Country in 2021

Figure 56. Egypt T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country T-cell engaging bsAbs Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of T-cell engaging bsAbs Drugs in 2021

Figure 62. Manufacturing Process Analysis of T-cell engaging bsAbs Drugs

Figure 63. Industry Chain Structure of T-cell engaging bsAbs Drugs

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles